JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saunders, J. P.
Right arrow Articles by Wills, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saunders, J. P.
Right arrow Articles by Wills, J. H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 112, Issue 2, 197-201, 1954
Copyright © 1954 by American Society for Pharmacology and Experimental Therapeutics


THE NEPHROTOXIC ACTION OF SODIUM TETRATHIONATE

J. Palmer Saunders 1 and J. Henry Wills 1

1 Pharmacology Branch, Chemical Corps Medical Laboratories, Army Chemical Center, Maryland

Renal function tests were performed on rabbits before and after intravenous administration of doses of sodium tetrathionate ranging from 10 to 100 mgm./ kgm. The 10 mgm./kgm. dose had no appreciable effect on tubular transport of glucose and chloride. It did decrease the tubular excretory mass (para-aminohippurate) and glomerular filtration rate (inulin) to some extent. Higher doses of tetrathionate produced decreases in all these variables. The 100 mgm./kgm. dose lowered inulin clearance to about 10 per cent of the control value, tubular transport of chlorides to about 20 per cent, tubular excretory mass to 5 per cent and tubular transport of glucose to zero.

These data suggest that low doses of tetrathionate affect the glomerulus and the proximal tubule about equally. At higher doses of tetrathionate, the proximal tubule becomes more seriously affected. As the dose of tetrathionate is increased still further, the distal tubule becomes involved also.

The implication of these findings for the use of tetrathionate in the treatment of peripheral vascular disorders in humans is discussed.

The authors wish to acknowledge the valuable technical assistance of Mr. Harold Green, Mr. S. Richard Heisey and Mrs. Aurora Bransford in carrying out this study.

Submitted on June 24, 1954







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1954 by the American Society for Pharmacology and Experimental Therapeutics.